Selected research
Market Structure
Global Pharmaceutical Safety Assessment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Pharmaceutical Safety Assessment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Pharmaceutical Safety Assessment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pharmaceutical Safety Assessment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharmaceutical Safety Assessment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Pharmaceutical Safety Assessment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pharmaceutical Safety Assessment include Eurofins, LabCorp, Fujifilm Wako, Charles River, SGS, Intertek Group, CTI, Frontage and Medicilon, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Pharmaceutical Safety Assessment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pharmaceutical Safety Assessment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pharmaceutical Safety Assessment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pharmaceutical Safety Assessment market size, projected growth trends, production technologies, key applications, and end-use industries.
Pharmaceutical Safety Assessment Segment by Company
Eurofins
LabCorp
Fujifilm Wako
Charles River
SGS
Intertek Group
CTI
Frontage
Medicilon
Wuxi Biologics
Pharmaron
Pharmaceutical Safety Assessment Segment by Type
Biological Drugs
Chemical Drugs
Pharmaceutical Safety Assessment Segment by Application
Clinical
Non-clinical
Pharmaceutical Safety Assessment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Safety Assessment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Safety Assessment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Safety Assessment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pharmaceutical Safety Assessment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Safety Assessment industry.
Chapter 3: Detailed analysis of Pharmaceutical Safety Assessment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Safety Assessmentrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Biological Drugs
- Chemical Drugs
Applications
- Clinical
- Non-clinical
Companies covered
- Eurofins
- LabCorp
- Fujifilm Wako
- Charles River
- SGS
- Intertek Group
- CTI
- Frontage
- Medicilon
- Wuxi Biologics
- Pharmaron
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Pharmaceutical Safety Assessment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Biological Drugs
- 1.2.3 Chemical Drugs
- 1.3 Market Analysis by Application
- 1.3.1 Global Pharmaceutical Safety Assessment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Clinical
- 1.3.3 Non-clinical
- 1.4 Global Market Growth Prospects
- 1.5 Global Pharmaceutical Safety Assessment Growth Trends by Region
- 1.5.1 Global Pharmaceutical Safety Assessment Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Pharmaceutical Safety Assessment Market Size by Region (2021-2026)
- 1.5.3 Pharmaceutical Safety Assessment Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Pharmaceutical Safety Assessment Market Dynamics
- 2.1 Pharmaceutical Safety Assessment Industry Trends
- 2.2 Pharmaceutical Safety Assessment Industry Drivers
- 2.3 Pharmaceutical Safety Assessment Industry Opportunities and Challenges
- 2.4 Pharmaceutical Safety Assessment Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Pharmaceutical Safety Assessment Revenue by Company (2021-2026)
- 3.2 Global Pharmaceutical Safety Assessment Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Pharmaceutical Safety Assessment Key Company Head office and Area Served
- 3.4 Global Pharmaceutical Safety Assessment Company, Product Type & Application
- 3.5 Global Pharmaceutical Safety Assessment Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Pharmaceutical Safety Assessment Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Pharmaceutical Safety Assessment Players Market Share by Revenue in 2025
- 3.6.3 2025 Pharmaceutical Safety Assessment Tier 1, Tier 2, and Tier 3
4 Pharmaceutical Safety Assessment Market by Type
- 4.1 Global Pharmaceutical Safety Assessment Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Pharmaceutical Safety Assessment Market Size by Type (2021-2032)
- 4.3 Global Pharmaceutical Safety Assessment Market Size Share by Type (2021-2032)
5 Pharmaceutical Safety Assessment Market by Application
- 5.1 Global Pharmaceutical Safety Assessment Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Pharmaceutical Safety Assessment Market Size by Application (2021-2032)
- 5.3 Global Pharmaceutical Safety Assessment Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Eurofins
- 6.1.1 Eurofins Company Information
- 6.1.2 Eurofins Business Overview
- 6.1.3 Eurofins Pharmaceutical Safety Assessment Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Eurofins Pharmaceutical Safety Assessment Product Portfolio
- 6.1.5 Eurofins Recent Developments
- 6.2 LabCorp
- 6.2.1 LabCorp Company Information
- 6.2.2 LabCorp Business Overview
- 6.2.3 LabCorp Pharmaceutical Safety Assessment Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 LabCorp Pharmaceutical Safety Assessment Product Portfolio
- 6.2.5 LabCorp Recent Developments
- 6.3 Fujifilm Wako
- 6.3.1 Fujifilm Wako Company Information
- 6.3.2 Fujifilm Wako Business Overview
- 6.3.3 Fujifilm Wako Pharmaceutical Safety Assessment Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Fujifilm Wako Pharmaceutical Safety Assessment Product Portfolio
- 6.3.5 Fujifilm Wako Recent Developments
- 6.4 Charles River
- 6.4.1 Charles River Company Information
- 6.4.2 Charles River Business Overview
- 6.4.3 Charles River Pharmaceutical Safety Assessment Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Charles River Pharmaceutical Safety Assessment Product Portfolio
- 6.4.5 Charles River Recent Developments
- 6.5 SGS
- 6.5.1 SGS Company Information
- 6.5.2 SGS Business Overview
- 6.5.3 SGS Pharmaceutical Safety Assessment Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 SGS Pharmaceutical Safety Assessment Product Portfolio
- 6.5.5 SGS Recent Developments
- 6.6 Intertek Group
- 6.6.1 Intertek Group Company Information
- 6.6.2 Intertek Group Business Overview
- 6.6.3 Intertek Group Pharmaceutical Safety Assessment Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Intertek Group Pharmaceutical Safety Assessment Product Portfolio
- 6.6.5 Intertek Group Recent Developments
- 6.7 CTI
- 6.7.1 CTI Company Information
- 6.7.2 CTI Business Overview
- 6.7.3 CTI Pharmaceutical Safety Assessment Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 CTI Pharmaceutical Safety Assessment Product Portfolio
- 6.7.5 CTI Recent Developments
- 6.8 Frontage
- 6.8.1 Frontage Company Information
- 6.8.2 Frontage Business Overview
- 6.8.3 Frontage Pharmaceutical Safety Assessment Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Frontage Pharmaceutical Safety Assessment Product Portfolio
- 6.8.5 Frontage Recent Developments
- 6.9 Medicilon
- 6.9.1 Medicilon Company Information
- 6.9.2 Medicilon Business Overview
- 6.9.3 Medicilon Pharmaceutical Safety Assessment Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Medicilon Pharmaceutical Safety Assessment Product Portfolio
- 6.9.5 Medicilon Recent Developments
- 6.10 Wuxi Biologics
- 6.10.1 Wuxi Biologics Company Information
- 6.10.2 Wuxi Biologics Business Overview
- 6.10.3 Wuxi Biologics Pharmaceutical Safety Assessment Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Wuxi Biologics Pharmaceutical Safety Assessment Product Portfolio
- 6.10.5 Wuxi Biologics Recent Developments
- 6.11 Pharmaron
- 6.11.1 Pharmaron Company Information
- 6.11.2 Pharmaron Business Overview
- 6.11.3 Pharmaron Pharmaceutical Safety Assessment Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Pharmaron Pharmaceutical Safety Assessment Product Portfolio
- 6.11.5 Pharmaron Recent Developments
7 North America
- 7.1 North America Pharmaceutical Safety Assessment Market Size (2021-2032)
- 7.2 North America Pharmaceutical Safety Assessment Market Size by Type
- 7.2.1 North America Pharmaceutical Safety Assessment Market Size by Type (2021-2026)
- 7.2.2 North America Pharmaceutical Safety Assessment Market Size by Type (2027-2032)
- 7.2.3 North America Pharmaceutical Safety Assessment Market Share by Type (2021-2032)
- 7.3 North America Pharmaceutical Safety Assessment Market Size by Application
- 7.3.1 North America Pharmaceutical Safety Assessment Market Size by Application (2021-2026)
- 7.3.2 North America Pharmaceutical Safety Assessment Market Size by Application (2027-2032)
- 7.3.3 North America Pharmaceutical Safety Assessment Market Share by Application (2021-2032)
- 7.4 North America Pharmaceutical Safety Assessment Market Size by Country
- 7.4.1 North America Pharmaceutical Safety Assessment Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Pharmaceutical Safety Assessment Market Size by Country (2021-2026)
- 7.4.3 North America Pharmaceutical Safety Assessment Market Size by Country (2027-2032)
- 7.4.4 North America Pharmaceutical Safety Assessment Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Pharmaceutical Safety Assessment Market Size (2021-2032)
- 8.2 Europe Pharmaceutical Safety Assessment Market Size by Type
- 8.2.1 Europe Pharmaceutical Safety Assessment Market Size by Type (2021-2026)
- 8.2.2 Europe Pharmaceutical Safety Assessment Market Size by Type (2027-2032)
- 8.2.3 Europe Pharmaceutical Safety Assessment Market Share by Type (2021-2032)
- 8.3 Europe Pharmaceutical Safety Assessment Market Size by Application
- 8.3.1 Europe Pharmaceutical Safety Assessment Market Size by Application (2021-2026)
- 8.3.2 Europe Pharmaceutical Safety Assessment Market Size by Application (2027-2032)
- 8.3.3 Europe Pharmaceutical Safety Assessment Market Share by Application (2021-2032)
- 8.4 Europe Pharmaceutical Safety Assessment Market Size by Country
- 8.4.1 Europe Pharmaceutical Safety Assessment Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Pharmaceutical Safety Assessment Market Size by Country (2021-2026)
- 8.4.3 Europe Pharmaceutical Safety Assessment Market Size by Country (2027-2032)
- 8.4.4 Europe Pharmaceutical Safety Assessment Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Pharmaceutical Safety Assessment Market Size (2021-2032)
- 9.2 China Pharmaceutical Safety Assessment Market Size by Type
- 9.2.1 China Pharmaceutical Safety Assessment Market Size by Type (2021-2026)
- 9.2.2 China Pharmaceutical Safety Assessment Market Size by Type (2027-2032)
- 9.2.3 China Pharmaceutical Safety Assessment Market Share by Type (2021-2032)
- 9.3 China Pharmaceutical Safety Assessment Market Size by Application
- 9.3.1 China Pharmaceutical Safety Assessment Market Size by Application (2021-2026)
- 9.3.2 China Pharmaceutical Safety Assessment Market Size by Application (2027-2032)
- 9.3.3 China Pharmaceutical Safety Assessment Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Pharmaceutical Safety Assessment Market Size (2021-2032)
- 10.2 Asia Pharmaceutical Safety Assessment Market Size by Type
- 10.2.1 Asia Pharmaceutical Safety Assessment Market Size by Type (2021-2026)
- 10.2.2 Asia Pharmaceutical Safety Assessment Market Size by Type (2027-2032)
- 10.2.3 Asia Pharmaceutical Safety Assessment Market Share by Type (2021-2032)
- 10.3 Asia Pharmaceutical Safety Assessment Market Size by Application
- 10.3.1 Asia Pharmaceutical Safety Assessment Market Size by Application (2021-2026)
- 10.3.2 Asia Pharmaceutical Safety Assessment Market Size by Application (2027-2032)
- 10.3.3 Asia Pharmaceutical Safety Assessment Market Share by Application (2021-2032)
- 10.4 Asia Pharmaceutical Safety Assessment Market Size by Country
- 10.4.1 Asia Pharmaceutical Safety Assessment Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Pharmaceutical Safety Assessment Market Size by Country (2021-2026)
- 10.4.3 Asia Pharmaceutical Safety Assessment Market Size by Country (2027-2032)
- 10.4.4 Asia Pharmaceutical Safety Assessment Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Pharmaceutical Safety Assessment Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Pharmaceutical Safety Assessment Market Size by Type
- 11.2.1 South America, Middle East & Africa Pharmaceutical Safety Assessment Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Pharmaceutical Safety Assessment Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Pharmaceutical Safety Assessment Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Pharmaceutical Safety Assessment Market Size by Application
- 11.3.1 South America, Middle East & Africa Pharmaceutical Safety Assessment Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Pharmaceutical Safety Assessment Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Pharmaceutical Safety Assessment Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Pharmaceutical Safety Assessment Market Size by Country
- 11.4.1 South America, Middle East & Africa Pharmaceutical Safety Assessment Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Pharmaceutical Safety Assessment Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Pharmaceutical Safety Assessment Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Pharmaceutical Safety Assessment Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst